Citation Impact
Citing Papers
Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
2011 Standout
LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1
2016 Standout
Emerging Concepts of Guanine Nucleotide-Binding Protein-Coupled Receptor (GPCR) Function and Implications for High Throughput Screening
2007
Evolution of the Cancer Stem Cell Model
2014 Standout
Ferroptosis: past, present and future
2020 Standout
Epithelial‐mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
2014
Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000
2008
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
2008
Allosteric Modulation of Muscarinic Acetylcholine Receptors
2007
The molecular hallmarks of epigenetic control
2016 Standout
Imaging beyond the proteome
2012 StandoutNobel
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
2009 Standout
Targeted delivery of platinum-based anticancer complexes
2013
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
2012 Standout
Nucleotide signalling during inflammation
2014 StandoutNature
Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes
2012
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology
2007
Quantifying Ligand Bias at Seven-Transmembrane Receptors
2011 StandoutNobel
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Sila‐Haloperidol, a Silicon Analogue of the Dopamine (D 2 ) Receptor Antagonist Haloperidol: Synthesis, Pharmacological Properties, and Metabolic Fate
2007
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine?s actions?
2004
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update
2011 Standout
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
2010 Standout
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist
2012 StandoutNatureNobel
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
2010 Standout
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Emerging Biological Principles of Metastasis
2017 Standout
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Teaching old receptors new tricks: biasing seven-transmembrane receptors
2010 StandoutNobel
EMT: 2016
2016 Standout
Overcoming chemotherapy resistance of ovarian cancer cells by liposomal cisplatin: Molecular mechanisms unveiled by gene expression profiling
2013
Nanomaterials: Applications in Cancer Imaging and Therapy
2011
The cancer stem cell: premises, promises and challenges
2011 Standout
Chemical calcium indicators
2008
DNA Damage-Mediated Induction of a Chemoresistant Niche
2010
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Relating protein pharmacology by ligand chemistry
2007 Standout
Ligand-targeted liposome design: challenges and fundamental considerations
2013
Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers
2008
Big opportunities for small molecules in immuno-oncology
2015
New cancer targets emerging from studies of the Von Hippel‐Lindau tumor suppressor protein
2010 StandoutNobel
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Liposomes as nanomedical devices
2015 Standout
Clonal evolution in cancer
2012 StandoutNature
Antibody‐Functionalized Porous Silicon Nanoparticles for Vectorization of Hydrophobic Drugs
2012
MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1
2011
The A, B, Cs of G-protein-coupled receptor pharmacology in assay development for HTS
2007
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Metastatic colonization by circulating tumour cells
2016 StandoutNature
G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions
2012
Tumour heterogeneity and resistance to cancer therapies
2017 Standout
Identification of Orthosteric and Allosteric Site Mutations in M2 Muscarinic Acetylcholine Receptors That Contribute to Ligand-selective Signaling Bias
2010
Impact of high-throughput screening in biomedical research
2011 Standout
Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase
2018 StandoutNobel
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Nanoparticles for photothermal therapies
2014 Standout
Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate
2016
Aging, Cellular Senescence, and Cancer
2012 Standout
Covalent Organic Frameworks: Design, Synthesis, and Functions
2020 Standout
Porous Silicon Nanodiscs for Targeted Drug Delivery
2014
Mesenchymal Stem Cells Derived from Dental Tissues vs. Those from Other Sources: Their Biology and Role in Regenerative Medicine
2009 Standout
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
2013
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Somatic stem cells for regenerative dentistry
2008
Microglial M1/M2 polarization and metabolic states
2015 Standout
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
Sila-Trifluperidol, a Silicon Analogue of the Dopamine (D2) Receptor Antagonist Trifluperidol: Synthesis and Pharmacological Characterization
2010
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Overcoming tumor resistance to cisplatin through micelle-mediated combination chemotherapy
2014
Works of Niels Eckstein being referenced
Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer Cells
2009
Allosteric Modulation of Muscarinic Receptor Signaling: Alcuronium-Induced Conversion of Pilocarpine from an Agonist into an Antagonist
2002
Acquired cisplatin resistance in the head–neck cancer cell line Cal27 is associated with decreased DKK1 expression and can partially be reversed by overexpression of DKK1
2008
Functional Screening of G Protein–Coupled Receptors by Measuring Intracellular Calcium with a Fluorescence Microplate Reader
2002
Epidermal Growth Factor Receptor Pathway Analysis Identifies Amphiregulin as a Key Factor for Cisplatin Resistance of Human Breast Cancer Cells
2007
NF546 [4,4′-(Carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-α,α′-diphosphonic Acid) Tetrasodium Salt] Is a Non-Nucleotide P2Y11 Agonist and Stimulates Release of Interleukin-8 from Human Monocyte-Derived Dendritic Cells
2009
In vitro differentiation of human dental follicle cells with dexamethasone and insulin
2005
Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro
2010
Platinum resistance in breast and ovarian cancer cell lines
2011
Pharmacological characterization of the benz[ d ]indolo[2,3- g ]azecine LE300, a novel type of a nanomolar dopamine receptor antagonist
2002
The Y-box binding protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma
2007